A Chirality‐Guided Molecular Recognition Strategy for Targeting Intrinsically Disordered Proteins
Chemistry – A European Journal · 01.06.2026 · 32 (21)
DOI: 10.1002/chem.70889 ↗Kurz gefasst
Fachartikel in der Zeitschrift Chemistry – A European Journal, online erschienen am 18.03.2026. Verfasst von Kenta Morita und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemical Science and Engineering, Graduate School of Engineering, Kobe University, Kobe, Japan. Hauptthemen laut MEDLINE: Amyloid beta-Peptides, Intrinsically Disordered Proteins, Peptide Fragments, Peptides. Die Arbeit nennt 29 Literaturangaben. Gefördert von: Nakatani Foundation for Advancement of Measuring Technologies in Biomedical Engineering, Toyota Physical and Chemical Research Institute, NORITZ Nukumori Foundation.
Abstract (Originalsprache)
Some peptide sequences are known to interact with their enantiomers to form stereocomplexes. However, the sequence‐dependent conditions required for stereocomplexation have not been thoroughly elucidated. Here, we present a systematic investigation of peptide stereocomplexation using short tripeptides and their enantiomers. Stereocomplexation was evaluated by aggregate formation in mixed aqueous solutions, and single‐crystal X‐ray diffraction revealed racemic crystals. Stereocomplexation was driven by hydrophobic interactions between phenylalanine residues and electrostatic interactions involving lysine and the C‐terminus. Thermodynamic and structural features of the complexation were further elucidated by calorimetry, simulations, and fluorescence assays. On the basis of these insights, a D‐peptide (Ac‐fffakr5‐NH 2 ) was rationally designed to target the –FFAE– motif of amyloid β42 (Aβ42), a pathological intrinsically disordered protein. This D‐peptide inhibited the fibrillization and cytotoxicity of Aβ42 in neuronal‐like cells, outperforming a clinical candidate, peptide drug RD2. These findings establish peptide stereocomplexation as a viable strategy for constructing sequence‐targeting ligands even against intrinsically disordered proteins.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Chemical Science and Engineering, Graduate School of Engineering, Kobe University, Kobe, Japan.
- Research Center for Membrane and Film Technology, Kobe University, Kobe, Japan.
- Graduate School of Science and Engineering, Kindai University, Osaka, Japan.
- Department of Chemistry, Graduate School of Science, Kobe University, Kobe, Japan.
ORCID-Profile: Kenta Morita, Eri Chatani, Tatsuo Maruyama
Förderung
- Nakatani Foundation for Advancement of Measuring Technologies in Biomedical Engineering
- Toyota Physical and Chemical Research Institute
- NORITZ Nukumori Foundation
- Koyanagi Zaidan
- Canon Foundation
- Suzuken Memorial Foundation
- Japan Agency for Medical Research and Development
- JSPS KAKENHI
Zitieren
APA
Morita, K., Seguchi, S., Hayashi, A., Miwa, H., Uchida, S., Sugimoto, K., Chatani, E., Tamura, A., & Maruyama, T. (2026). A Chirality‐Guided Molecular Recognition Strategy for Targeting Intrinsically Disordered Proteins. Chemistry – A European Journal, 32(21). https://doi.org/10.1002/chem.70889
Vancouver
Morita K, Seguchi S, Hayashi A, Miwa H, Uchida S, Sugimoto K, et al. A Chirality‐Guided Molecular Recognition Strategy for Targeting Intrinsically Disordered Proteins. Chemistry – A European Journal. 2026;32(21). doi:10.1002/chem.70889
BibTeX
@article{Morita2026,
author = {Morita, Kenta and Seguchi, Shiho and Hayashi, Ayaka and Miwa, Haruhiko and Uchida, Satoru and Sugimoto, Kunihisa and Chatani, Eri and Tamura, Atsuo and Maruyama, Tatsuo},
title = {A Chirality‐Guided Molecular Recognition Strategy for Targeting Intrinsically Disordered Proteins},
journal = {Chemistry – A European Journal},
year = {2026},
volume = {32},
number = {21},
doi = {10.1002/chem.70889}
}
EUVIMED